These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33001202)

  • 1. Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With Outcomes.
    Dworeck C; Redfors B; Angerås O; Haraldsson I; Odenstedt J; Ioanes D; Petursson P; Völz S; Persson J; Koul S; Venetsanos D; Ulvenstam A; Hofmann R; Jensen J; Albertsson P; Råmunddal T; Jeppsson A; Erlinge D; Omerovic E
    JAMA Netw Open; 2020 Oct; 3(10):e2018735. PubMed ID: 33001202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Redfors B; Dworeck C; Haraldsson I; Angerås O; Odenstedt J; Ioanes D; Petursson P; Völz S; Albertsson P; Råmunddal T; Persson J; Koul S; Erlinge D; Omerovic E
    Eur Heart J; 2019 Apr; 40(15):1202-1210. PubMed ID: 30851037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precatheterization Use of P2Y
    Badri M; Abdelbaky A; Li S; Chiswell K; Wang TY
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.
    Lattuca B; Belardi D; Demattei C; Schmutz L; Cornillet L; Ledermann B; Macia JC; Iemmi A; Gervasoni R; Roubille F; Cung TT; Robert P; Messner-Pellenc P; Leclercq F; Cayla G
    J Invasive Cardiol; 2018 Sep; 30(9):348-354. PubMed ID: 30012889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Pretreatment With Oral P2Y12 Inhibitors and Cardiovascular and Bleeding Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Meta-analysis.
    Dawson LP; Chen D; Dagan M; Bloom J; Taylor A; Duffy SJ; Shaw J; Lefkovits J; Stub D
    JAMA Netw Open; 2021 Nov; 4(11):e2134322. PubMed ID: 34797371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.
    Bonello L; Laine M; Camoin-Jau L; Noirot F; Guieu R; Dignat-George F; Paganelli F; Frere C
    Thromb Haemost; 2015 Oct; 114(4):702-7. PubMed ID: 26311415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Society Guidelines on Trends in Use of Newer P2Y
    Mohamed MO; Kontopantelis E; Alasnag M; Abid L; Banerjee A; Sharp ASP; Bourantas C; Sirker A; Curzen N; Mamas MA
    J Am Heart Assoc; 2024 May; 13(9):e034414. PubMed ID: 38700032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry.
    Völz S; Petursson P; Odenstedt J; Ioanes D; Haraldsson I; Angerås O; Dworeck C; Hirlekar G; Myredal A; Albertsson P; Råmunddal T; Redfors B; Omerovic E
    J Am Heart Assoc; 2020 Jul; 9(14):e015990. PubMed ID: 32662350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Effron MB; Wang TY; Fonarow GC; Henry TD; Zettler ME; Baker BA; McCoy LA; Peterson ED
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):242-250. PubMed ID: 28988425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Temporal evolution of antithrombotic therapy use in patients with acute coronary syndromes undergoing percutaneous coronary intervention in Italy: comparison between the EYESHOT and SCOPE registries].
    De Luca L; Pennacchi M; Musumeci G; D'Ascenzo F; Gallo P; Rigattieri S; Granatelli A; Berti S; Gulizia MM; De Servi S; Bolognese L;
    G Ital Cardiol (Rome); 2018 Feb; 19(2):101-110. PubMed ID: 29531382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor Utilization in Patients With Non-ST Elevation Acute Coronary Syndromes in Romania.
    Cotoban AG; Udroiu CA; Vinereanu D
    Am J Ther; 2021 Apr; 28(3):e271-e283. PubMed ID: 33852478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    You SC; Rho Y; Bikdeli B; Kim J; Siapos A; Weaver J; Londhe A; Cho J; Park J; Schuemie M; Suchard MA; Madigan D; Hripcsak G; Gupta A; Reich CG; Ryan PB; Park RW; Krumholz HM
    JAMA; 2020 Oct; 324(16):1640-1650. PubMed ID: 33107944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes.
    Joshi RR; Hossain R; Morton AC; Ecob R; Judge HM; Wales C; Walker JV; Karunakaran A; Storey RF
    Platelets; 2014; 25(6):416-22. PubMed ID: 24111601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of P2Y
    Almendro-Delia M; Hernández-Meneses B; Padilla-Rodríguez G; Blanco-Ponce E; Arboleda-Sánchez JA; Rodríguez-Yáñez JC; Soto-Blanco JM; Fernández-García I; Castillo-Caballero JM; García-Rubira JC; Hidalgo-Urbano R
    J Am Coll Cardiol; 2024 Jun; 83(25):2629-2639. PubMed ID: 38897672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.
    Montalescot G; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; ten Berg JM; Miller DL; Costigan TM; Goedicke J; Silvain J; Angioli P; Legutko J; Niethammer M; Motovska Z; Jakubowski JA; Cayla G; Visconti LO; Vicaut E; Widimsky P;
    N Engl J Med; 2013 Sep; 369(11):999-1010. PubMed ID: 23991622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty Registry.
    Jurga J; Szummer KE; Lewinter C; Mellbin L; Götberg M; Zwackman S; Nilsson J; Völz S; Erlinge D; Persson J; Omerovic E; Jernberg T; Venetsanos D
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e010849. PubMed ID: 34592825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Rationale of the APELOT Trial: A Randomized, Open-Label, Multicenter, Phase IV Study to Evaluate the Antiplatelet Effect of Different Loading Dose of Ticagrelor in Patients With Non-ST Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Liu HL; Wei YJ; Jin ZG; Zhang J; Ding P; Yang SL; Luo JP; Ma DX; Liu Y; Han W
    Medicine (Baltimore); 2016 May; 95(22):e3756. PubMed ID: 27258504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.
    Dayoub EJ; Seigerman M; Tuteja S; Kobayashi T; Kolansky DM; Giri J; Groeneveld PW
    JAMA Intern Med; 2018 Jul; 178(7):943-950. PubMed ID: 29799992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Franchi F; Rollini F; Rivas A; Wali M; Briceno M; Agarwal M; Shaikh Z; Nawaz A; Silva G; Been L; Smairat R; Kaufman M; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2019 Apr; 139(14):1661-1670. PubMed ID: 30630341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.